 "Unichem Labs up 9% as USFDA completes Ghaziabad plant with no observations")
Shares of Unichem Laboratories have surged 9% to Rs 283 per share on the BSE in early morning trade after the pharmaceutical company said it has not received any observations from US health regulator following completion of inspection of the company’s facility in Ghaziabad, Uttar Pradesh.
“The Company's formulation manufacturing facility at Ghaziabad was inspected by the United States Food and Drug Administration (USFDA) from 16/04/2018 to 20/04/2018,” Unichem Labs said in a regulatory filing.
The Inspection concluded with zero observations. This inspection also covered one of the first to file molecules, it added.
At 09:18 am; the stock was trading 8% higher at Rs 280 as compared to 0.14% decline in the S&P BSE Sensex. A combined 139,746 shares changed hands on the counter on the BSE and NSE.
“The Company's formulation manufacturing facility at Ghaziabad was inspected by the United States Food and Drug Administration (USFDA) from 16/04/2018 to 20/04/2018,” Unichem Labs said in a regulatory filing.
The Inspection concluded with zero observations. This inspection also covered one of the first to file molecules, it added.
At 09:18 am; the stock was trading 8% higher at Rs 280 as compared to 0.14% decline in the S&P BSE Sensex. A combined 139,746 shares changed hands on the counter on the BSE and NSE.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%